Could ClearVue tech have eased Spain’s pain?
ClearVue’s solar glass turns buildings into energy hubs, cutting costs, easing grid strain and paving the way for potentially greener cities.
ClearVue’s solar glass turns buildings into energy hubs, cutting costs, easing grid strain and paving the way for potentially greener cities.
White Cliff Minerals MD Troy Whittaker joins Barry FitzGerald to dig into a big time red metal reveal in the Great White North.
ASX medtechs are taking brain diagnostics beyond the hospital or clinical settings to the front lines of care for better outcomes.
As the gold bull run continues, investors and explorers are looking to promising domestic projects in Queensland.
The ASX 200 pushed into the green on a choppy Monday as fears around Trump’s tariffs trade war were somewhat quelled.
One of two of Opthea’s phase III trials for a common eye disease has failed to meet its primary endpoints, thus casting doubts on the company’s solvency.
Neurizon Therapeutics continues to make strides on its NUZ-001 treatment for ALS, paving the way for next stage clinical trials.
Assays of up to 3.7% Li2O confirm potential of Perpetual’s recently acquired Renaldinho licence to host high-grade spodumene.
Star Minerals (ASX:SMS) continues to advance its Tumblegum South project as the gold price reaches new record highs.
Greenvale Energy has wrapped up a $1.8m placement to begin exploring its Oasis uranium project in Queensland.
Hillgrove is targeting first ore from the Nugent deposit at Kanmantoo this year as drilling flagged resource growth potential.
Terra Metals has produced three high-grade concentrates at Dantes Reefs, which could become a vital link in the critical minerals supply chain.
Original URL: https://www.couriermail.com.au/business/stockhead/page/181